Paradoxical Embolic Stroke : Diagnosis and Management


Paradoxical embolization describes the passage of material, typically thrombus, from venous circulation into the systemic arterial circulation via a shunt. Presence of a right-to-left shunt is often the result of an atrial cardiac defect. In 1877, Dr. Julius Cohnheim, a Prussian pathologist, first proposed this mechanism after identifying a large atrial defect during the autopsy of a 35-year-old woman who suffered a fatal ischemic stroke. Three years later, Dr. Moritz Litten, a German internal medicine physician, further supported this proposition with an additional compelling case when an autopsy of a 43-year-old woman with multiple systemic emboli identified extensive femoral vein thrombosis. After enlisting the support of Professor Rudolf Virchow, closer inspection revealed a right atrial thrombus and a large atrial defect.

Paradoxical embolism was once thought to be an exceedingly rare cause of ischemic stroke, but multiple studies reported an increased prevalence of patent foramen ovale (PFO) in patients with cryptogenic stroke (stroke with unclear etiology), particularly in young patients, suggesting that paradoxical embolism may be more common than previously considered. Even still, given the heterogeneous nature of stroke and the high prevalence of PFO in the general population, it is challenging to determine the pathophysiologic relevance of PFO and right-to-left shunt in patients with stroke. While it has been of a topic of much debate, recent clinical trials have helped clarify the value of PFO closure for secondary stroke prevention in select patients. The following issues will be addressed in this chapter:

  • Pathophysiology of PFO in stroke

  • Complete evaluation of young patients with stroke

  • Medical management of PFO

  • Percutaneous closure of PFO

  • Atrial septal defects

  • Atrial septal aneurysms

  • Patients with PFO and underlying hypercoagulability

Pathophysiology of Patent Foramen Ovale in Stroke

PFO is a common congenital cardiac finding. While in utero, the positioning of the septum primum and secundum acts as a one-way valve, facilitating right-to-left shunting of oxygenated blood provided via the umbilical vein. At the time of birth, pulmonary ventilation dramatically increases pulmonary perfusion and reverses the previous right-to-left pressure gradient, leading to a functional closure of the foramen ovale. In about 75% of healthy adults, permanent anatomical closure occurs via fibrous adhesions, while in the remaining 25%, the shunt persists, resulting in a PFO. The one-way nature of the valve is often preserved, so right-to-left shunting can occur when right-sided cardiac pressures increase, such as with Valsalva maneuver, coughing, or a number of pathologic conditions. Importantly, the right-to-left shunt acts as a potential conduit for paradoxical embolization, or it may also foster stagnant blood, ultimately promoting in situ thrombus formation. PFO may also be associated with increased risk of atrial arrhythmia.

The relationship between PFO and stroke is strongest among young patients with cryptogenic stroke in case-control studies. The Risk of Paradoxical Embolism (RoPE) study merged 12 cohorts of cryptogenic stroke patients, 2546 total patients, in order to investigate factors associated with the presence of PFO and to determine the likelihood that a patient's PFO was pathogenically related to the stroke ( Box 39.1 ). In brief, the younger the patient, and the fewer traditional risk factors present, the more likely a PFO is to be identified during the workup, and thus the more likely it was to have been involved in the genesis of the stroke. The score can help physicians counsel patients and determine a course of action. The higher the number, the more likely the PFO was to be related to the stroke, with a score of ≥6 suggesting that it is more likely than not that the PFO was pathogenic. While observational studies have been inconsistent, the presence of certain echocardiographic features may convey a higher risk of stroke ( Box 39.2 ). Finally, some clinical clues may suggest that a PFO was causally related to the stroke, including history of DVT or pulmonary embolism, recent prolonged travel, migraine, and a Valsalva-type maneuver at onset of the stroke.

Box 39.1
Calculating and Interpreting the Risk of Paradoxical Embolism Score

Characteristics Points (Add to Calculate Total Score)
No history of hypertension 1
No history of diabetes 1
No prior stroke or TIA 1
Nonsmoker 1
Presence of cortical infarct on imaging 1
Age 18–29 years 5
Age 30–39 years 4
Age 40–49 years 3
Age 50–59 years 2
Age 60–69 years 1
RoPE Score PFO Attributable Fraction (95% CI) 2-Year Stroke Risk (95% CI)
0–3 0% (0–4) 16% (9–24)
4 38% (25–48) 9% (4–14)
5 34% (21–45) 3% (0–6)
6 62% (54–68) 4% (2–7)
7 72% 9 66–76) 2% (0–4)
8 84% (79–87) 3% (0–5)
9–10 88% (83–91) 1% (0–2)

PFO , Patent foramen ovale; RoPE , risk of paradoxical embolism; TIA , transient ischemic attack.

Box 39.2
Possible High-Risk Patent Foramen Ovale Characteristics

  • Large size of PFO

  • Large right-to-left shunt

  • Spontaneous right-to-left shunt

  • Presence of atrial septal aneurysm

  • Greater PFO flap mobility

  • Prominent eustachian valve

  • Prominent Chiari network

PFO , Patent foramen ovale.

Complete Evaluation of A Young Patient With Stroke

It is first important to discuss that there are multiple conditions that cause focal neurologic dysfunction that can mimic a stroke, but these would entail a different workup and treatment, as described in Table 39.1 . If a stroke is confirmed, secondary prevention depends on identifying the mechanism of the first event, if possible. Thus a thorough workup following a stroke is critical to optimally reducing stroke risk. Because of the high prevalence of PFO in the general population, and low risk of stroke related to PFO, it should not be considered the proximate cause until the workup is complete and an alternative source of stroke has been ruled out.

TABLE 39.1
Stroke Mimics
Stroke Mimic Clinical Clues Evidence
Atypical migraine
  • Commonly symptoms occur in the context of a migraine headache in a patients with a history of migraines.

  • Rarely can occur in absence of headache (acephalgic migraine)

  • Neurologic deficit evolves or spreads over a few minutes, and resolves over hours.

  • Deficit may resemble a classic migraine aura that the patient has previously experienced.

  • May recur in stereotypical fashion

  • Family history, particularly in the case of hemiplegic migraine

  • MRI without evidence of acute infarction

  • In rare cases, cortical edema, diffusion restriction, meningeal enhancement, hyperperfusion, or prominent vascular dilation may be seen contralateral to the deficit

  • Complete clinical resolution of the neurologic deficit

  • Diagnosis is clinical, but genetic testing may rarely be pursued as there are multiple known genetic mutations that result in familial hemiplegic migraine

Seizure
  • History of epilepsy or structural brain lesion

  • Neuro deficit most often preceded by jerking, head turning, or loss of awareness/consciousness (may be unwitnessed)

  • Postictal confusion, tongue biting, or incontinence

  • Eye deviation may be in the direction of the hemiparesis while patient is actively seizing. (During postictal weakness, eye deviation will be away from the hemiparesis.)

  • Progressive resolution of deficit with time

  • MRI without evidence of acute infarction (Rarely, prolonged seizure will lead to cortical diffusion restriction.)

  • EEG with seizure or epileptiform activity (After the seizure, the EEG may be normal or show nonspecific focal slowing.)

Structural lesion (e.g., tumor, abscess, subdural hematoma)
  • Onset of symptoms is not typically sudden

  • History of malignancy (in particular known metastatic disease)

  • Non-contrast CT may show evidence of extra-axial hematoma, mass, or edema

  • Contrast-enhanced CT or MRI (preferred over CT) will better differentiate

Metabolic derangement (e.g., hypoglycemia)
  • History of diabetes, fasting, or use of hypoglycemic meds (insulin or sulfonylureas)

  • Associated symptoms such as diaphoresis or altered mental status

  • Rapid clinical improvement with correction of glucose

  • Significantly depressed or elevated glucose

  • MRI without evidence of acute infarction

Somatoform disorder (e.g., conversion)
  • Fluctuating or inconsistent exam findings

  • Nonlocalizing deficits

  • Task-dependent or “give-way” weakness

  • Clear emotional trigger preceding the symptoms

  • MRI without evidence of acute infarction

CT , Computed tomography; EEG, electroencephalography; MRI , magnetic resonance imaging.

Table 39.2 reviews the various potential stroke etiologies that should be considered in a young patient. While stroke is a clinical diagnosis, evaluation typically starts with brain imaging. Computed tomography (CT) is useful in the emergency setting in order to exclude an intracerebral hemorrhage, but in the absence of clear ischemic injury on CT, magnetic resonance imaging (MRI) may provide more information regarding the size and distribution of infarcts, timing, and evidence of chronic strokes. While MRI is not always necessary, in the context of young patients with unclear cause of stroke, MRI is helpful to identify acute and/or chronic infarcts in multiple territories, which would be consistent with cardioembolism. Alternatively, MRI may confirm that the injury is exclusively small-vessel disease.

TABLE 39.2
Stroke Etiologies in Young Patients
Stroke Etiology Frequency Clinical Clues Evidence
Cardioembolism
  • Common in young patients due to PFO, valvular abnormalities, endocarditis, cardiac tumors, or thrombus

  • Large neurologic deficit most pronounced at onset

  • History of heart failure, valvular disease, or atrial fibrillation (less common in young patients)

  • Clinical concern for endocarditis (IV drug use, fevers, positive blood cultures, or additional embolic phenomena)

  • Atrial fibrillation found on cardiac rhythm monitor

  • Clear high-risk source of embolism identified on echocardiogram

  • MRI with infarcts in multiple vascular territories

Arterial dissection
  • Common in young patients

  • Recent trauma, neck manipulation, or viral illness (None of these are obligatory.)

  • History of, or clinical concern for, connective tissue disorder

  • Vascular imaging with tapering of vessel in a location not typical of atherosclerosis

  • Crescent appearance on MRI T1-fat sat

Vasoactive drugs
  • Common in young patients

  • History of sympathomimetic drug use including decongestants, cocaine, amphetamines, but also consider marijuana and synthetic cannabinoids

  • Urine toxicology screen identifying vasoactive drugs

  • Segmental intracranial vessel narrowing or spasm may be seen, but not necessary

Hematologic abnormality
  • Rare, but more common in young patients

  • History of thrombophilia or prior clotting event

  • Family history of thrombophilia

  • Active malignancy, particularly adenocarcinoma

  • History of spontaneous abortions

  • Oral contraceptive or hormonal supplementation

  • History or family history of sickle cell disease

  • Thrombophilia identified on lab testing

  • Abnormal hemoglobin electrophoresis

  • Concomitant diagnosis of malignancy known to be associated with thrombophilia

Large artery atherosclerosis
  • Rare in young patients

  • History of carotid or vertebral stenosis

  • Prior radiation exposure to the head and neck

  • Bruit on physical examination

  • Vascular imaging with stenosis in the relevant territory

Small artery disease
  • Rare in young patients

  • Risk factor such as hypertension, diabetes, hyperlipidemia, and smoking

  • Acute infarct <1.5 cm in deep perforator vasculature

  • MRI with chronic appearing small vessel ischemic disease

Vasculitis
  • Rare

  • Multiple strokes over a short period of time

  • Headaches, cognitive decline, and B-type symptoms

  • Elevated inflammatory markers in some cases

  • Vascular imaging with multisegmental narrowing

  • Inflammatory CSF profile

  • Biopsy revealing perivascular transluminal inflammation

Mitochondrial disease
  • Rare

  • Stroke occurs during systemic stress

  • History of muscle weakness or fatigability

  • Seizures

  • Family history of mitochondrial disease or stroke at a young age

  • Stroke crosses arterial borders on MRI

  • Lesions resolve and expand over time

  • Lactic acidosis

  • Elevated CSF lactate during acute stroke

  • Genetic testing confirms diagnosis in most cases

CADASIL
  • Rare

  • Family history of migraine, depression, early stroke, and dementia

  • MRI with extensive subcortical white matter injury, particularly in the anterior temporal lobes, external capsule, and corona radiata

CADASIL , Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; CSF, cerebrospinal fluid; MRI , magnetic resonance imaging; PFO , patent foramen ovale.

Vascular imaging is critical to addressing the possibility of a large artery process. If the stroke occurred within the distribution of the carotid arteries, Doppler ultrasonography is a reasonable minimal screening test for carotid bifurcation disease. However, it is important to note that dissection is a common mechanism for stroke in young patients, and ultrasound is not as sensitive to detect dissection, as the lesion is often more distal than ultrasound can insonate. Thus CT angiogram or MR angiogram (MRA) of the head and neck is appropriate to more thoroughly evaluate the complete cervicocephalic vasculature, in addition to the posterior circulation (vertebrobasilar system). This may also provide insight into the possibility of an underlying vasculopathy. If a vasculopathy is identified and is of uncertain cause, a conventional angiogram may also be warranted.

A complete cardiac workup is critical to ruling out a cardiac source of embolism. Although it is considerably less prevalent in younger populations, atrial fibrillation is a well-characterized cause of stroke. All patients should have an EKG and at least 24 hours of rhythm monitoring during admission. After discharge, long-term monitoring increases the likelihood of capturing occult atrial fibrillation, but the low rate of atrial fibrillation in patients under 45 likely limits the utility in that population. Every stroke patient should undergo an echocardiogram to assess for cardioembolic sources such as reduced ejection fraction, cardiomyopathy, regional wall motion abnormalities, noncompaction, valvular vegetations, tumors, intracardiac thrombus, aortic arch atheroma, and of course PFO. The gold standard for PFO detection is direct visualization of intracardiac shunting with agitated saline during transesophageal echocardiogram (TEE). TEE is also most sensitive to detect valve lesions, left atrial appendage thrombus, and aortic pathology. Transthoracic echocardiography is most helpful to identify ventricular pathology and is generally less sensitive for detection of PFO. For detection of right-to-left shunt, transcranial Doppler ultrasonography (TCD) of the cerebral vessels during intravenous injection of agitated saline is comparable to TEE, but fails to directly visualize the PFO, cannot differentiate cardiac from noncardiac right-to-left shunts, and most importantly, does not allow for detection of other mechanisms of stroke and transient ischemic attack (TIA) originating in the heart and aorta.

Laboratory studies address a number of common and uncommon causes of stroke. As a part of the initial evaluation, a complete blood count, prothrombin time, partial thromboplastin time, cholesterol panel, and hemoglobin A1C should be collected. Inflammatory markers such as ESR or CRP are an appropriate screen for vasculitis—in particular temporal arteritis in the older population. If there is concern for vasculopathy or vasculitis, a more comprehensive autoimmune screen is warranted, but will not be described in detail here. In patients thought to be at risk of cancer with an otherwise unexplained stroke mechanism, an elevated D-dimer may increase concern for hypercoagulability of malignancy, and elevated pro-BNP may increase the suspicion of occult atrial fibrillation. A toxicology screen should be performed in all patients because of the relationship between sympathomimetic drugs and stroke with or without vasculopathy. The potential relationship between stroke and marijuana remains controversial, but there are recent reports of stroke associated with use of synthetic cannabinoids. In young patients with first stroke, strong family history of early stroke or known thrombophilia, or recurrent unexplained stroke, a hypercoagulable screen beyond basic coagulation studies should be performed. In the acute setting, this should include prothrombin gene mutation, factor V Leiden, homocysteine, and antiphospholipid antibody panel (including lupus anticoagulant, anticardiolipin antibodies, and beta-2-glycoprotein). After the acute phase, protein C, protein S, and antithrombin III can be measured, as these values may be perturbed in the setting of acute thrombosis. For a more detailed description of the thrombophilia workup, please refer to Chapter 22 , Box 22.1 .

If a complete stroke workup ( Box 39.3 ) reveals a potential cause of stroke, such as large vessel atherosclerosis, arterial dissection, or atrial fibrillation, secondary stroke prevention should target this known mechanism. Because PFO is common, associated with a low risk of stroke relative to other known mechanisms, and can reasonably be treated with antiplatelet or anticoagulant medication described as follows, it should generally be considered incidental if another compelling mechanism is identified.

Box 39.3
Complete Stroke/Transient Ischemic Attack Workup for Patient Under 60 Years of Age

  • Brain imaging:

    • MRI to fully characterize the distribution of acute lesions as well as chronic lesions

  • Vessel imaging of head and neck:

    • CTA or MRA to identify large vessel atherosclerotic process, underlying vasculopathy, or dissection

    • Conventional angiogram may be necessary to fully exclude underlying vasculopathy if high index of suspicion or concern based on noninvasive imaging

  • Cardiac workup:

    • Transthoracic and/or transesophageal echocardiogram to identify potential cardiac source of emboli, such as reduced ejection fraction, segmental wall motion abnormalities, valvular vegetation, aortic athero, thrombus, or mass. Agitated saline “bubble” study to assess for right-to-left shunting

    • EKG and telemetry while in hospital, in addition to long-term rhythm monitoring for atrial fibrillation after discharge (lower utility in young patients)

  • Lab work:

    • Lipid panel and Hgb A1C to screen for modifiable stroke risk factors

    • Toxicology screen

    • ESR and RPR to screen for treatable infection, inflammation, or malignancy

    • Hypercoagulable screen (while not a component of every stroke, it is appropriate in a young patient with PFO and no alternative etiology, or when there is family history of hypercoagulability)

MRI , Magnetic resonance imaging; MRA , magnetic resonance angiogram; PFO , patent foramen ovale.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here